Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Lupin Limited
LUPINLupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women's health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India. Address: Kalpataru Inspire, Mumbai, India, 400055
Analytics
Preço Alvo de Wall Street
168 276.42 INRRácio P/E
36.6272Rendimento de dividendos
0.39 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave LUPIN
Análise de Dividendos LUPIN
Crescimento de dividendos em 5 anos
-20 %Crescimento contínuo
1 anoTaxa de pagamento em média de 5 anos
-2 %Histórico de Dividendos LUPIN
Avaliação de ações LUPIN
Relatório LUPIN
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |